BGPT: Paper Review: Mutation-Specific and Common Phosphotyrosine Signatures of KRAS G12D and G13D Alleles

Fuel Your Discoveries

Quick Explanation Copied

Fast take

Using isogenic SW48 cells carrying KRAS G12D or G13D, the paper reports mutation-specific and shared changes in the phosphotyrosine proteome, with G12D linked to membrane/adherens-junction proximal signaling and G13D linked to non-receptor tyrosine kinases, MAPK activity, and metabolic regulators. It further identifies MPZL1 (phospho-Y263) as a G12D-enriched phospho-event whose knockdown reduces G12D-cell viability more than G13D—a candidate mutation-specific dependency signal.

Source: 10.1021/acs.jproteome.0c00587

Long Explanation

Paper Review (visual-first): Mutation-Specific and Common Phosphotyrosine Signatures of KRAS G12D and G13D Alleles

DOI: 10.1021/acs.jproteome.0c00587 • Published Oct 8, 2020

What the study actually did (grounded in methods)

Model: isogenic SW48 colorectal cancer cells with endogenous-context KRAS mutations: parental (KRAS WT), G12D, and G13D.
Quant strategy: 3-state SILAC (light/medium/heavy) across the three lines with 3 biological replicates; phosphotyrosine peptides enriched via antibody-based immunoaffinity, analyzed by LC–MS/MS.
Stats thresholds: hyperphosphorylation considered significant at fold-change ≥ 1.75 and p ≤ 0.05; total-protein changes at fold-change ≥ 2 and p ≤ 0.05.
Validation: western blot and siRNA knockdown (notably MPZL1) and proliferation/viability assays.

Visual 1 — Coverage & significance-call summary

Values above come directly from the paper’s extracted quantitative summary: 1,086 unique phosphotyrosine sites identified (from 676 proteins), 812 sites quantified across replicates, and 308/280 sites measured in all 3 biological replicates for G12D/Parental and G13D/Parental ratios.

Visual 2 — Shared vs mutation-specific hyperphosphorylation

The paper states: 11 sites are hyperphosphorylated in both G12D and G13D vs parental; 52 sites are increased only in G12D; and 42 sites are increased only in G13D.

Visual 3 — Total proteome upregulation counts

The paper states 134 and 182 proteins were significantly more abundant (≥2-fold, p ≤ 0.05) in G12D and G13D cells relative to parental, respectively.

Mutation-specific storyline (what the paper claims, and what can be inferred)

G12D

Higher global tyrosine phosphorylation than G13D in the reported Western/global phosphotyrosine comparisons.
G12D-specific phosphotyrosine signature includes strong hyperphosphorylation of MPZL1 at Y263 and phosphorylation changes in several focal adhesion / adherens junction associated proteins (as described in results text).
Functional link: MPZL1 knockdown decreases proliferation/viability in G12D cells more than G13D cells (and KRAS knockdown decreases viability in both mutants but not parental).

G13D

G13D-specific phosphotyrosine signature highlights hyperphosphorylation of proteins enriched in metabolic processes and also phosphosites on kinases including MAPK family members (per text).
Total proteome differences show enrichment for some distinct proteins (e.g., ALDH3A1/other examples are named in results text).

Visual 4 — Dependency candidate: MPZL1 Y263 (concept map)

The map summarizes the paper’s textual chain: MPZL1 Y263 is G12D-specific by phosphotyrosine MS and is validated by phospho-specific western blot; pooled MPZL1 knockdown reduces G12D cell viability more than G13D.

Critical review (skeptical, evidence-weighted)

Strengths

Controlled comparison via isogenic lines reduces background genetic heterogeneity as a driver of signaling differences, directly supporting the mutation-specific framing (within the limits of a single cellular context).
Orthogonal measurement layers: they combine phosphotyrosine proteomics with total proteome profiling and then validate at least one key candidate (MPZL1 Y263) with biochemical assays and perturbation (siRNA).

Methodological blind spots & how they could bias interpretation

Coverage and thresholding: the study applies fold-change and p-value cutoffs for “significant” calls; this can miss smaller but biologically meaningful shifts or create boundary artifacts. The paper itself uses these explicit thresholds.
Correlation vs causation: phosphorylation changes do not automatically identify the upstream kinase(s) or determine whether the modification is a driver, a mediator, or a downstream readout. The paper acknowledges mechanistic hypotheses for some changes (e.g., possible rewiring via altered effector binding), which are testable but not fully established for most sites.
Single-model generalizability: all mutation-specific signaling conclusions are derived from one colorectal cell line background (SW48). Even with isogenic control, signaling networks can be context-dependent across tissues/genetic states.

What would most strongly disprove the “mutation-specific MPZL1 dependency” angle?

Replicate MPZL1 knockdown across additional independent KRAS G12D/G13D mutant backgrounds (still isogenic within each background) and show the differential effect is robust. The paper’s key dependency evidence is limited to its experimental context.
Demonstrate that MPZL1 effect tracks with Y263 phosphorylation causally (e.g., phosphosite-mutation experiments). The paper validates the phosphorylation difference and perturbs expression, but causal phosphosite necessity is not established in the provided text.

Bespoke follow-ups on BGPT (for deeper dissection)

Author Reviews (jump into BGPT for each author)

Feedback:

Updated: March 28, 2026